HIGHLIGHTS
- who: Shiran Pinchevski-Kadir from the (UNIVERSITY) have published the research work: Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF, in the Journal: (JOURNAL)
- what: This study provides efficacy and safety data from the longest follow-up to date, with reassuring evidence that this group of drugs is extremely well tolerated and results in excellent clinical outcomes, with 80% achieving complete treatment response. Interestingly, in this study the authors report a very low rate of side effects, despite a mean follow-up of more than 3 years. This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.